Equities

Tsumura & Co

Tsumura & Co

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)3,950.00
  • Today's Change54.00 / 1.39%
  • Shares traded142.60k
  • 1 Year change+41.93%
  • Beta0.7029
Data delayed at least 20 minutes, as of Sep 19 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments78,07594,75267,552
Total Receivables, Net66,83857,90954,756
Total Inventory117,616101,72592,750
Prepaid expenses------
Other current assets, total18,76313,93414,362
Total current assets281,292268,320229,420
Property, plant & equipment, net104,05893,41590,040
Goodwill, net8,3508,4808,513
Intangibles, net8,9036,1673,815
Long term investments17,26813,18712,327
Note receivable - long term------
Other long term assets3,6422,8823,364
Total assets428,254396,813350,981
LIABILITIES
Accounts payable19,82816,44313,676
Accrued expenses------
Notes payable/short-term debt10,31310,31310,313
Current portion long-term debt/capital leases15,1109477
Other current liabilities, total23,30620,35521,809
Total current liabilities68,55747,20545,875
Total long term debt54,68169,63939,609
Total debt80,10480,04649,999
Deferred income tax2,2671,1901,466
Minority interest24,56220,19918,339
Other liabilities, total7,3856,5335,922
Total liabilities157,452144,766111,211
SHAREHOLDERS EQUITY
Common stock30,14230,14230,142
Additional paid-in capital13,73913,73913,732
Retained earnings (accumulated deficit)205,804194,224182,929
Treasury stock - common(2378)(1068)(682)
Unrealized gain (loss)8,5835,3204,997
Other equity, total14,9129,6908,652
Total equity270,802252,047239,770
Total liabilities & shareholders' equity428,254396,813350,981
Total common shares outstanding767677
Treasury shares - common primary issue0.830.370.25
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.